Consider PID

Consider Pelvic Inflammatory Disease (PID)

Don't forget to consider PID when chlamydia is diagnosed in a patient with female reproductive organs. 

Quick guide for best practice chlamydia case management

test orangetest orangePID blueretest orangePM orange

Why is checking for PID symptoms important?

Chlamydia is the most commonly detected STI associated with PID.1 It is estimated that approximately 15% of new chlamydia infections will progress to symptomatic PID if left untreated.2 

Diagnosing PID

Clinicians should have a low threshold for diagnosing PID in young sexually active women and women diagnosed with an STI if they are experiencing pelvic or lower abdominal pain where no other cause can be identified. 

For help diagnosing PID, see:

Chlamydia is the most commonly detected STI associated with PID, followed by Neisseria gonorrhoea and Mycoplasma genitalium. In many cases however, no causal orgaism is identified.1 

Patient resources for PIDQandA PID

For a patient factsheet about PID, click below

PID Factsheet

For all patient resources, click below

Patient resources

GP resources for PID

Need more help?

Contact your local Family Planning organisation or specialist sexual health clinic for further support. 

For all GP resources, click below

GP Resources

Key guidelines for chlamydia case management

For PID diagnosis, treatment and management

Australian STI Management Guidelines (updated March 2018). 

For guidance on acute abdominal pain in women, including differential diagnosis, speculum and bimanual examinations, and a PID flowchart

NSW Health STI Programs Unit (STIPU) Acute Abdominal Pain in Women

retest orange


1. Goller JL, De Livera AM, Fairley CK, et al. Characteristics of pelvic inflammatory disease where no sexually transmitted infection is identified: a cross-sectional analysis of routinely collected sexual health clinic data. Sex Transm Infect. 2017;93(1):68. Available from:
2. Price M J, Ades A, Soldan K, et al. The natural history of Chlamydia trachomatis infection in women: a multi parameter evidence synthesis. Health Technol Assess. 2016;20(22). Available from:

MoCCA is funded by the National Health and Medical Research Council (APP1150014) and is a collaboration between the University of Melbourne and our project investigators and partner organisations. Click here for a list of our collaborators.

uomlogo footer trim